What is the Nifty Pharma Index value today?
The latest value of Nifty Pharma Index is 21804.05 as of 29th August 2025.What is the shareholder returns of Nifty Pharma Index Index?
The Nifty Pharma Index has given the following returns in the past:- Past 1 week | -1.82%
- Past 1 month | -4.10%
- Past 3 months | 0.99%
- Past 6 months | 9.68%
- Past 1 year | -4.69%
- Past 3 years | 73.80%
- Past 5 years | 96.79%
What is the 52 week high value of Nifty Pharma Index?
The 52 week high value of Nifty Pharma Index is 23907.90, as of 29th August 2025.What is the 52 week low value of Nifty Pharma Index?
The 52 week low value of Nifty Pharma Index is 19121.10, as of 29th August 2025.What are the components of Nifty Pharma Index?
The components of Nifty Pharma Index, along with their weightage, are as follows -- Sun Pharmaceutical Industries Ltd | 22.35%
- Cipla Ltd | 11.73%
- Divi's Laboratories Ltd | 10.26%
- Dr Reddy's Laboratories Ltd | 9.74%
- Lupin Ltd | 6.01%
Nifty Pharma Index Today
NIFTY PHARMA Share Price
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ETFs tracking NIFTY PHARMA
PHARMABEES
NIFTY PHARMA Performance & Key Metrics
NIFTY PHARMA Performance & Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 35.12 | 5.17 | 0.74% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.73% | 20 | 1 |
About NIFTY PHARMA
About NIFTY PHARMA
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return-0.02% | 0.02% | -0.02% | 100.00% | Free float Mcap759.73 Weight100.00% | |
ABBOTINDIA 0.02% Return attribution0.00% | 0.02% | 0.00% | 2.16% | 16.38 Weight2.16% | |
AJANTPHARM 1.22% Return attribution-0.02% | 1.22% | -0.02% | 1.37% | 10.40 Weight1.37% | |
ALKEM 1.35% Return attribution-0.04% | 1.35% | -0.04% | 2.73% | 20.77 Weight2.73% | |
AUROPHARMA 0.16% Return attribution0.01% | 0.16% | 0.01% | 3.60% | 27.37 Weight3.60% | |
BIOCON 1.39% Return attribution-0.04% | 1.39% | -0.04% | 2.69% | 20.43 Weight2.69% | |
ZYDUSLIFE 0.25% Return attribution0.01% | 0.25% | 0.01% | 3.23% | 24.52 Weight3.23% | |
CIPLA 0.58% Return attribution0.07% | 0.58% | 0.07% | 11.73% | 89.10 Weight11.73% | |
DIVISLAB 0.01% Return attribution-0.00% | 0.01% | -0.00% | 10.26% | 77.97 Weight10.26% | |
DRREDDY 0.02% Return attribution0.00% | 0.02% | 0.00% | 9.74% | 73.99 Weight9.74% | |
GLENMARK 0.67% Return attribution-0.02% | 0.67% | -0.02% | 3.53% | 26.86 Weight3.53% | |
GRANULES 5.35% Return attribution0.05% | 5.35% | 0.05% | 0.94% | 7.15 Weight0.94% | |
IPCALAB 2.40% Return attribution-0.06% | 2.40% | -0.06% | 2.54% | 19.30 Weight2.54% | |
J B Chemicals and Pharmaceuticals Ltd JBCHEPHARM 1.05% Return attribution0.02% | 1.05% | 0.02% | 1.84% | 14.01 Weight1.84% | |
LAURUSLABS 0.59% Return attribution-0.02% | 0.59% | -0.02% | 4.13% | 31.38 Weight4.13% | |
LUPIN 0.39% Return attribution-0.02% | 0.39% | -0.02% | 6.01% | 45.64 Weight6.01% | |
NATCOPHARM 0.59% Return attribution-0.01% | 0.59% | -0.01% | 0.99% | 7.52 Weight0.99% | |
Sun Pharmaceutical Industries Ltd SUNPHARMA 0.55% Return attribution0.12% | 0.55% | 0.12% | 22.35% | 169.82 Weight22.35% | |
TORNTPHARM 0.48% Return attribution-0.02% | 0.48% | -0.02% | 4.66% | 35.43 Weight4.66% | |
GLAND 0.81% Return attribution-0.02% | 0.81% | -0.02% | 1.95% | 14.85 Weight1.95% | |
MANKIND 0.11% Return attribution-0.00% | 0.11% | -0.00% | 3.53% | 26.83 Weight3.53% |
ETFs tracking NIFTY PHARMA Index
ETFs tracking NIFTY PHARMA Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
PHARMABEES — | — | High | 0.21% | 0.02% |
NIFTY PHARMA Events
NIFTY PHARMA Events
Dividends
Corp. Actions
Announcements
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NIFTY PHARMA Upcoming Dividends
NIFTY PHARMA Upcoming Dividends
No upcoming dividends are available
NIFTY PHARMA Past Dividends
NIFTY PHARMA Past Dividends
Cash DividendNATCOPHARM
NATCOPHARMEx DateEx DateAug 19, 2025
Interim
Interim | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 19, 2025
Cash DividendGLAND
GLANDEx DateEx DateAug 14, 2025
Final
Final | Div/Share: ₹18.00
Dividend/Share
₹18.00
Ex DateEx Date
Aug 14, 2025
Cash DividendALKEM
ALKEMEx DateEx DateAug 8, 2025
Final
Final | Div/Share: ₹8.00
Dividend/Share
₹8.00
Ex DateEx Date
Aug 8, 2025
Cash DividendMANKIND
MANKINDEx DateEx DateAug 8, 2025
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 8, 2025
Cash DividendAUROPHARMA
AUROPHARMAEx DateEx DateAug 8, 2025
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 8, 2025
NIFTY PHARMA News & Opinions
NIFTY PHARMA News & Opinions
Articles & Videos
Stock markets dive in early trade as steep 50% U.S. tariffs dent investors’ sentiment
2 days ago•The Hindu
Key triggers for these three pharma stocks - Dr Reddy’s Lab, Cipla, Biocon
2 days ago•The Hindu Businessline
Optimistic on GST reforms for pharmaceutical sector: Dr Reddy’s Chairman Satish Reddy
3 days ago•The Hindu Businessline
Pharma industry hopes for relief from GST reforms
3 days ago•The Hindu
Dr Reddy’s Expects New GST Framework To Address Critical Issues Impacting Pharma Sector
3 days ago•Bloomberg Quint
Dr Reddy’s expects new GST framework to address critical issues impacting pharma sector
3 days ago•Economic Times
Stricter shelf life rule a bitter pill to swallow for pharma companies
4 days ago•Economic Times
Sun Pharma, Lupin, Dr Reddy’s Drop Up To 4% As Trump’s Pharma Shock Spooks Investors
4 days ago•News18
Sun Pharma shares slip 3% after BofA downgrade on premium valuations
4 days ago•Economic Times
Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation
5 days ago•Economic Times
